NYSE$OSCR

Oscar Health Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Oscar Health's financial performance reflected strong momentum and ongoing ability to leverage technology to drive top line growth and improve efficiencies.

Oscar Health announced its Q1 2022 financial results, showing significant growth in premiums and membership. The company reported a net loss of $77 million but reaffirmed its 2022 outlook across all metrics.

  • Membership as of March 31, 2022 reached 1,073,595, a 98% increase YoY.
  • Direct and assumed policy premiums were $1.7 billion, a 104% increase YoY.
  • Premiums earned totaled $955 million, a 159% increase YoY.
  • Net loss was $77 million, a decrease of $12 million YoY.

Headline financials

Total Revenue

$973M

Previous: $369M+163.3%
EPS (adj)

-$0.36

Previous: -$0.98+63.3%
Medical loss ratio

77.4%

Previous: 74.4%+4.0%
Free Cash Flow

-$75.2M

Previous: -$87.4M+14.0%
Net Income

-$75.2M

Previous: -$87.4M+14.0%
Operating Income

-$68.5M

Previous: -$62.5M-9.6%
Gross Profit

$241M

Previous: $111M+117.7%
Cash & Equivalents

$2.07B

Previous: $2.32B-10.9%
Total Assets

$4.35B

Previous: $3.59B+21.0%
Stock-Based Comp

$27.7M

Previous: $19.1M+44.9%

Revenue & EPS history

Oscar Health · Revenue · Quarterly

$973M

Q1 2022+163.3%vs Q1 2021
Beat estimate in 3 of 11 quarters(27%)
ActualEstimate

Forward guidance

Oscar is reaffirming its 2022 outlook across all metrics.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+3.7%

Avg return

Earnings day

+5.6%

Avg return

5 days after

+7.5%

Avg return

30 days after

64%

16 / 25 earnings

Positive

+30.0%

Q1 2025

Best reaction

-23.9%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.7%+22.6%+36.6%
Q4 2025+1.7%+6.0%+2.7%
Q3 2025-2.8%-12.8%-1.5%
Q1 2025+30.0%+28.7%+18.0%
Q4 2024+3.1%-3.7%+4.5%
Q3 2024-12.9%-12.8%+0.4%
Q2 2024+7.2%+4.4%-1.4%
Q1 2024+9.3%+14.1%+2.8%
Q4 2023+22.7%+27.5%+7.7%
Q3 2023+23.5%+24.5%+42.0%
Q2 2023+8.6%+1.9%-10.5%
Q1 2023-8.8%-6.6%+17.8%
Q4 2022+21.0%+36.2%-3.9%
Q3 2022-23.9%-4.5%-11.3%
Q2 2022+19.9%+21.1%-3.7%
Q1 2022-8.9%-2.0%-25.0%
Q4 2019+6.3%+2.5%+39.1%
Q4 2021+2.4%+15.6%+21.9%
Q3 2020-2.4%-6.3%-12.7%
Q3 2021-23.3%-25.2%-33.0%
Q2 2020-16.4%-11.8%+19.4%
Q2 2021-0.9%-12.0%+17.9%
Q4 2020+15.2%+14.5%+23.1%
Q1 2020+15.2%+14.5%+23.1%
Q1 2021+3.6%+4.2%+14.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro